BioAscent has secured £1.6m in funding from Maven Capital Partners (“Maven”). The investment will facilitate BioAscent’s growth through its unique offering of integrated drug discovery, and compound management services, as well as the Compound Cloud library of lead-like pharma compounds, … Continued
Read More
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK. Clients from across the globe will be able to access highly experienced teams specialising in these … Continued
Read More
NEWHOUSE, UK (20 September 2017): BioAscent Discovery Limited has announced an agreement with Pivot Park Screening Centre (PPSC, Oss, The Netherlands), under which it is managing PPSC’s entire screening collection of over 300,000 compounds. This new library consolidates BioAscent’s position as … Continued
Read More
BioAscent Discovery Limited has taken delivery of Medivir AB’s compound collection of around 56,000 samples, to manage on an outsourced basis. To ensure business continuity during this transfer process, the complete collection was transferred within three working days, and all compounds … Continued
Read More
NEWHOUSE, UK (11 July 2017): BioAscent Discovery Limited (www.bioascent.com) has announced the appointment of Paul Smith as CEO, in preparation for the expansion of BioAscent’s discovery services offering. Having established its position as one of Europe’s leading outsourced compound management … Continued
Read More
BioAscent and Merz Pharmaceuticals GmbH, part of the Merz Pharma Group, have entered into a Master Service Agreement (MSA), under which BioAscent provides a comprehensive outsourced compound management service for a significant part of Merz Pharmaceutical’s compound collection, in both … Continued
Read More
NEWHOUSE, UK (8 June 2016): BioAscent Discovery has launched Compound Cloud, a unique new service for early-stage drug discovery, providing rapid online access to a diverse collection of IP-free, high-quality chemicals for screening. The service applies the cloud-computing concept to … Continued
Read More